PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood disorder after reviewing encouraging results from a phase 3 study.

While Biden touted those legislative achievements in his aborted reelection campaign, bill-signing ceremonies became vanishingly rare in the last half of his presidency. Bill-signing ceremonies can be ...

While Biden touted those legislative achievements in his aborted reelection campaign, bill-signing ceremonies became vanishingly rare in the last half of his presidency. Bill-signing ceremonies ...

Amaze Lab New Rare Blood Group Discovered After 50 Year Mystery Posted: January 3, 2025 | Last updated: January 3, 2025 What blood type are you? That question usually results in a response of A, B ...

Chinese researchers have found that treatment for an invasive, noncancerous brain tumour that causes complications including diabetes could lie in a cheap medication often prescribed for high ...

Researchers have discovered that a low-cost blood pressure medication may effectively treat a noncancerous but invasive brain tumor. Craniopharyngioma is a rare, noncancerous brain tumor near the ...

NOAH IS ONE OF LESS THAN A THOUSAND PEOPLE IN THE WORLD WITH ERDHEIM-CHESTER DISEASE, A RARE BLOOD CANCER THAT ATTACKS YOUR ENTIRE BODY, AFFECTING YOUR MOTOR SKILLS, SPEECH, AND OVERALL MOBILITY.

The dust is beginning to settle after Philippe Clement finally ended his Old Firm hoodoo. Rangers smashed Celtic 3-0 in the New Year curtain raiser at Ibrox and while it's a long way from blowing ...

A brain scan shows the white mass of a solid tumour on the left (UCLA) Researchers from the Chinese Academy of Scientists found that a common blood pressure medicine, amlodipine besylate ...

An inter-departmental research team has conducted an analytic real-world cohort study on the association of clozapine, a highly efficacious antipsychotic drug, with the incidence of blood cancer.

The team's observations of the patients showed that the absolute risk of blood cancer is very rare. In the cohort of 10,000 patients followed over a period of about seven years, only 39 developed ...